Nisha Pongpech, Anchalee Avihingsanon, Romanee Chaiwarith, Pacharee Kantipong, David Boettiger, Jeremy Ross, Sasisopin Kiertiburanakul
A prediction model for pretreatment HIV RNA level ≤100,000 copies/ml would provide a useful tool for selection of abacavir (ABC) or rilpivirine (RPV) in the first-line regimen in a resource-limited setting. Factors associated with pre-treatment HIV RNA ≤100,000 copies/ml were determined from a cohort of 1,223 patients divided into a derivation (n = 873) and the remaining in a validation group. Their median [interquartile range (IQR)] age was 36.3 (30.5-42.9) years, CD4 count 122 (39-216) cells/mm3 and pre-treatment HIV RNA level 100,000 (32,449-229,777) copies/ml...
November 2018: Southeast Asian Journal of Tropical Medicine and Public Health